Clinica Psichiatrica, 1st floor
- Address
- Via Romagna 16, 09127 Cagliari, Italy
Clinica Psichiatrica - Treatment-Resistant Psychiatric Disorders Center
Clinica Psichiatrica, 1st floor, is a specialized psychiatric research center dedicated to advancing treatment strategies for severe mental health conditions. The center focuses on innovative approaches to treatment-resistant psychiatric disorders, particularly investigating early-intensified pharmacological interventions following first-line treatment failures. Their research program emphasizes comparative effectiveness studies that evaluate optimized treatment protocols against standard care approaches.
- Treatment-resistant schizophrenia, schizoaffective disorder, and schizophreniform disorder management
- Bipolar depression treatment optimization and early intervention strategies
- Major depressive disorder with inadequate treatment response
The center employs rigorous randomized controlled trial methodologies to assess symptom severity changes using validated assessment tools such as the Montgomery Åsberg Depression Rating Scale (MADRS) for mood disorders and the Positive And Negative Syndrome Scale (PANSS) for psychotic disorders. By investigating four to six-week intensified pharmacological treatment regimens, the center aims to establish evidence-based protocols that can improve outcomes for patients who experience first-time treatment failure on their initial medication regimens, ultimately reducing the burden of treatment-resistant psychiatric conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 52 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 48 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinica Psichiatrica, 1st floor
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major depressive disorder and bipolar depression compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment. | Universitair Medisch Centrum Utrecht | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 52 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bupropion Hydrochloride | 3 | Unknown | 2024-08-29 | 2025-02-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.